The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 2014 ACR/ARHP Annual Meeting: Wellness Ultimate Goal in Rheumatology Patient Care

2014 ACR/ARHP Annual Meeting: Wellness Ultimate Goal in Rheumatology Patient Care

January 1, 2015 • By Susan Bernstein

  • Tweet
  • Email
Print-Friendly Version / Save PDF

You Might Also Like
  • 2014 ACR/ARHP Annual Meeting: Patient-Centered Outcomes Research Gaining Support
  • 2014 ACR/ARHP Annual Meeting: Methotrexate Use in Patients with RA
  • 2014 ACR/ARHP Annual Meeting: Rheumatology Drug Updates, Safety News
Explore This Issue
January 2015
Also By This Author
  • Self-Driven Care Can be Difficult for Adolescents Transitioning from Pediatric to Adult Rheumatology Provider
Tailored and targeted

BOSTON—Wellness is difficult to define or measure, for both rheumatologists and their patients. However, wellness should be our ultimate goal as we move into the future of medicine, said Leroy Hood, MD, PhD, president of the Institute for Systems Biology (ISB) in Seattle.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Ninety-nine percent of our effort and resources have focused on the disease side. I want to show you how important I think wellness is going to be,” said Dr. Hood, who delivered the opening lecture, P4 Medicine Is Transforming Healthcare: A Longitudinal, Framingham-like Study of 100,000 Well Patients Over 20 to 25 Years, at the ACR/ARHP Annual Meeting in Boston on Nov. 15.

Dr. Hood outlined five goals of his laboratory’s visionary work in personalized, genomics-driven medicine. He spoke about creating new metrics to quantify wellness, using these metrics to optimize wellness for patients with chronic disease, utilizing these metrics to analyze the earliest mechanisms of transition to active disease, creating a wellness industry, and taking all of these findings to the developing world. He spun a future vision of a “systems approach” to medicine, where multidisciplinary teams analyze a patient’s genomic profile, family medical history, and lifestyle, and then craft a personalized risk assessment and plan to prevent health problems.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Bold New Direction

This paradigm shift won’t be easy, because scientists are conservative and reluctant to embrace change, Dr. Hood said.

“Most biologists were firmly opposed to the Human Genome Project, as was the National Institutes of Health!” he noted. “I realized then that biology departments of the future needed to be cross-disciplinary to develop the analytical tools we needed to process all the data.” Medicine embraced technology and engineering, and new diagnostic and treatment tools were the result, Dr. Hood said.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE
Dr. Hood
Dr. Hood

In 2005, Dr. Hood and his organization articulated their concept of systems or P4 medicine: predictive, preventive, personalized and participatory. By 2008, he began a strategic partnership with the government of Luxembourg to develop new, systems-driven technologies with a $100 million investment over five years. In 2013, Dr. Hood and his team proposed the 100K Wellness Project, a longitudinal, digital, Framingham-like study of 100,000 well participants to analyze their genetic data, laboratory test results and lifestyle factors, such as smoking and diet, to create disease-risk profiles.

Using a cloud-based, systems approach, rheumatologists could one day match patients to proper drugs for their conditions or identify new drug target candidates.

Pages: 1 2 3 | Single Page

Filed Under: Meeting Reports Tagged With: Bernstein, Drugs, genomics, medicine, Research, rheumatology, wellnessIssue: January 2015

You Might Also Like:
  • 2014 ACR/ARHP Annual Meeting: Patient-Centered Outcomes Research Gaining Support
  • 2014 ACR/ARHP Annual Meeting: Methotrexate Use in Patients with RA
  • 2014 ACR/ARHP Annual Meeting: Rheumatology Drug Updates, Safety News
  • 2014 ACR/ARHP Annual Meeting: Seeking the Patient Perspective in Real-World Settings

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.